Cleo vs Viz.ai
Detailed side-by-side comparison to help you choose the right tool
Cleo
Automation & Workflows
AI-powered clinical decision support platform for acute care hospitals, providing real-time patient deterioration detection, sepsis prediction, and workflow optimization to improve outcomes and reduce clinician burnout.
Was this helpful?
Starting Price
CustomViz.ai
🔴DeveloperBusiness AI Solutions
AI-powered medical imaging platform that accelerates diagnosis and treatment of critical conditions
Was this helpful?
Starting Price
PaidFeature Comparison
Scroll horizontally to compare details.
Cleo - Pros & Cons
Pros
- ✓Aims to consolidate deterioration detection, sepsis prediction, and capacity management into a single acute-care-focused platform, potentially reducing the need to procure and integrate multiple point solutions
- ✓Claims direct integration into existing EHR workflows (Epic, Cerner) so clinicians don't need to learn a separate application
- ✓Configurable alert sensitivity reportedly allows clinical informatics teams to tune the system to their facility's tolerance for alert fatigue
- ✓Describes explainable risk scores showing contributing factors, which if validated would enable clinicians to make informed decisions rather than relying on black-box outputs
- ✓Covers multiple acute care use cases within a single platform, unlike competitors that typically specialize in one domain (imaging, operations, or sepsis scoring alone)
Cons
- ✗Independent verification of the product, its customer base, and clinical outcomes is extremely limited — no peer-reviewed studies, named references, or specific outcome data are publicly available
- ✗Enterprise-only pricing (estimated at $50,000+/year based on comparable platforms) makes it inaccessible for small or rural hospitals without dedicated AI budgets
- ✗As a newer entrant, Cleo lacks the established install base and track record of competitors like Qventus, Viz.ai, or Epic's native tools, increasing procurement risk
- ✗Implementation requires a multi-week integration and calibration period, which may delay time-to-value by 2–3 months
- ✗Limited to acute care settings — organizations looking for outpatient, primary care, or population health AI will need a separate solution
- ✗FDA clearance status is not publicly documented, and no clinical validation studies are available in public databases such as PubMed
Viz.ai - Pros & Cons
Pros
- ✓Improved diagnostic accuracy
- ✓24/7 monitoring
- ✓Data-driven insights
- ✓Cost reduction
Cons
- ✗Regulatory requirements
- ✗Privacy concerns
- ✗Cannot replace human doctors
Not sure which to pick?
🎯 Take our quiz →🔒 Security & Compliance Comparison
Scroll horizontally to compare details.
🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.